Literature DB >> 19897555

Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year.

W Xu1, J-P Collet, S Shapiro, Y Lin, T Yang, C Wang, J Bourbeau.   

Abstract

Unreported chronic obstructive pulmonary disease (COPD) exacerbations are common, but their intermediate-to-long-term impacts on health-related quality of life (HRQoL) are unknown. The aim of the present study was to examine the impact of unreported exacerbations on HRQoL at 1 yr. A multicentric prospective cohort study in 491 COPD patients was conducted in China. HRQoL was measured using the St George's Respiratory Questionnaire (SGRQ). Other measurements included sociodemographic, clinical, psychosocial and treatment profiles. Patients were monitored monthly for 12 months to document exacerbations (at least one symptom worsening for > or =48 h). Patients were categorised into six groups: no exacerbation, one unreported exacerbation only, more than one unreported exacerbation only, one reported exacerbation only, more than one reported exacerbation only, and both unreported and reported exacerbations. Generalised estimating equations were used to estimate the adjusted associations between exacerbations and HRQoL change. A total of 466 unreported and 410 reported exacerbations were recorded. Compared with patients with no exacerbations, the change in SGRQ total score was similar amongst patients with one unreported exacerbation (adjusted mean change 1.22 points (95% CI -4.05-6.48)), but significantly worse among patients with more than one unreported exacerbation (4.61 (95% CI 0.09-9.13)). Development and evaluation of self-management programmes emphasising early recognition of exacerbations and consequent action appear to be warranted.

Entities:  

Mesh:

Year:  2009        PMID: 19897555     DOI: 10.1183/09031936.00079409

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  36 in total

1.  The Short-term Impact of Symptom-defined COPD Exacerbation Recovery on Health Status and Lung Function.

Authors:  Lindsey T Murray; Nancy K Leidy
Journal:  Chronic Obstr Pulm Dis       Date:  2018-01-24

2.  Associations between illness duration and health-related quality of life in specified mental and physical chronic health conditions: results from a population-based survey.

Authors:  Lucy Busija; Jeretine Tan; Kerrie M Sanders
Journal:  Qual Life Res       Date:  2017-05-12       Impact factor: 4.147

3.  Detecting exacerbations using the Clinical COPD Questionnaire.

Authors:  Jaap C A Trappenburg; Irene Touwen; Gerdien H de Weert-van Oene; Jean Bourbeau; Evelyn M Monninkhof; Theo J M Verheij; Jan-Willem J Lammers; Augustinus J P Schrijvers
Journal:  Health Qual Life Outcomes       Date:  2010-09-16       Impact factor: 3.186

4.  Capturing Exacerbations of Chronic Obstructive Pulmonary Disease with EXACT. A Subanalysis of FLAME.

Authors:  Stefan M Frent; Kenneth R Chapman; Michael Larbig; Alexander Mackay; Robert Fogel; Florian S Gutzwiller; Steven Shen; Francesco Patalano; Donald Banerji; Konstantinos Kostikas; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2019-01-01       Impact factor: 21.405

5.  Validation of COPDPredict™: Unique Combination of Remote Monitoring and Exacerbation Prediction to Support Preventative Management of COPD Exacerbations.

Authors:  Neil Patel; Kathryn Kinmond; Pauline Jones; Pamela Birks; Monica A Spiteri
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-06-21

6.  How do COPD patients respond to exacerbations?

Authors:  Jaap C A Trappenburg; David Schaap; Evelyn M Monninkhof; Jean Bourbeau; Gerdien H de Weert-van Oene; Theo J M Verheij; Jan-Willem J Lammers; Augustinus J P Schrijvers
Journal:  BMC Pulm Med       Date:  2011-08-19       Impact factor: 3.317

Review 7.  Self management for patients with chronic obstructive pulmonary disease.

Authors:  Marlies Zwerink; Marjolein Brusse-Keizer; Paul D L P M van der Valk; Gerhard A Zielhuis; Evelyn M Monninkhof; Job van der Palen; Peter A Frith; Tanja Effing
Journal:  Cochrane Database Syst Rev       Date:  2014-03-19

8.  The impact of body mass index on inpatient- versus outpatient-treated chronic obstructive pulmonary disease exacerbations.

Authors:  Ariane Jacob; Catherine Laurin; Kim L Lavoie; Gregory Moullec; Maxine Boudreau; Catherine Lemière; Simon Bacon
Journal:  Can Respir J       Date:  2013-05-28       Impact factor: 2.409

9.  Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.

Authors:  Margaret K Pasquale; Shawn X Sun; Frank Song; Heather J Hartnett; Stephen A Stemkowski
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-11-01

10.  Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT).

Authors:  Eric D Bateman; Kenneth R Chapman; Dave Singh; Anthony D D'Urzo; Eduard Molins; Anne Leselbaum; Esther Garcia Gil
Journal:  Respir Res       Date:  2015-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.